Live Breaking News & Updates on Clin Cardiol|Page 8
Stay updated with breaking news from Clin cardiol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively Relative to Placebo in a Post Hoc Analysis ....
Investegate announcements from Amarin Corporation plc, New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes ....
Late-Breaking Data Show VASCEPA/VAZKEPA Significantly Reduced STEMI by 40% and NSTEMI by 27% in Pre-Specified, Post Hoc Analyses Data Presented During Late-Breaking Science Session at European ....
Comparing the subjective cardiovascular disease risk perception level of patients with the nonlaboratory Framingham Risk Score among hypertensive patients ....